Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 22 studies with search of: | "Sibutramine" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes
|
||||
2 | Completed |
Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives
|
||||
3 | Not yet recruiting |
Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women
|
||||
4 | Active, not recruiting |
A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients.
|
||||
5 | Completed |
Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population
|
||||
6 | Completed |
A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.
|
||||
7 | Terminated |
Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects
|
||||
8 | Recruiting |
Treatment of Binge Eating in Obese Patients in Primary Care
|
||||
9 | Completed |
A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.
|
||||
10 | Completed |
A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
|
||||
11 | Active, not recruiting |
Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
|
||||
12 | Completed |
Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS
|
||||
13 | Completed |
A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
|
||||
14 | Completed |
Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients
|
||||
15 | Completed |
Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity
|
||||
16 | Completed |
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
|
||||
17 | Completed |
The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
|
||||
18 | Completed |
A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects
|
||||
19 | Completed |
A Comparative Study of KES524 in Patients With Obesity Disease
|
||||
20 | Active, not recruiting |
LOSS- Louisiana Obese Subjects Study
|
Previous Page | Studies Shown (1-20) | Next (21-22) |